• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷酸环化酶可提高心肌病患者的生存率。

Adenylyl cyclase increases survival in cardiomyopathy.

作者信息

Roth David M, Bayat Hamed, Drumm Jeffrey D, Gao Mei Hua, Swaney James S, Ander Aziz, Hammond H Kirk

机构信息

VA San Diego Healthcare System, San Diego, CA 92161, USA.

出版信息

Circulation. 2002 Apr 23;105(16):1989-94. doi: 10.1161/01.cir.0000014968.54967.d3.

DOI:10.1161/01.cir.0000014968.54967.d3
PMID:11997288
Abstract

BACKGROUND

To test the hypothesis that increased cardiac adenylyl cyclase type VI (AC(VI)) content, which results in increased cAMP generation, would increase survival in cardiomyopathy, we crossbred mice with Gq-associated cardiomyopathy and those with cardiac-directed expression of AC(VI). We also assessed myocardial hypertrophy after prolonged cardiac expression of Gq versus coexpression of Gq and AC(VI).

METHODS AND RESULTS

Three experimental groups, Gq/AC (double positive), Gq, and control (double negative), were studied. Survival was increased by cardiac-directed expression of AC(VI) (P<0.0001), and Gq/AC mice had survival rates indistinguishable from control mice. Myocardial hypertrophy developed in older Gq mice but was abrogated by cardiac expression of AC(VI), as documented by the ratio of ventricular weight to tibial length (Gq, 11.93+/-0.99 mg/mm, n=11; Gq/AC, 8.00+/-0.73 mg/mm, n=9; P<0.01) and by left ventricular cardiac myocyte size (Gq, 2800+/-254 microm2, n=4; Gq/AC, 1721+/-166 microm2, n=5; P<0.01). Hearts of Gq mice were dilated, and function was impaired. Concurrent expression of AC reduced end-diastolic diameter (Gq, 4.20+/-0.15 mm, n=12; Gq/AC, 3.68+/-0.12 mm, n=7; P<0.05) and increased fractional shortening (Gq, 32+/-1%, n=12; Gq/AC, 41+/-2%, n=7; P<0.001). Cardiac myocytes from Gq/AC mice showed increased forskolin-stimulated cAMP production (Gq, 3.8+/-1.3 fmol/cell, n=5; Gq/AC, 10.7+/-2.6 fmol/cell, n=6; P<0.02), documenting increased AC function.

CONCLUSIONS

Cardiac-directed expression of AC(VI) restores myocyte AC function, improves heart function, increases cAMP generation, abrogates myocardial hypertrophy, and increases survival in Gq cardiomyopathy.

摘要

背景

为验证以下假说,即心脏中VI型腺苷酸环化酶(AC(VI))含量增加会导致环磷酸腺苷(cAMP)生成增加,进而提高心肌病小鼠的生存率,我们将患有与Gq相关心肌病的小鼠与心脏定向表达AC(VI)的小鼠进行杂交。我们还评估了长期心脏表达Gq与共表达Gq和AC(VI)后心肌肥大的情况。

方法与结果

研究了三个实验组,即Gq/AC(双阳性)、Gq和对照组(双阴性)。心脏定向表达AC(VI)可提高生存率(P<0.0001),Gq/AC小鼠的生存率与对照小鼠无显著差异。老年Gq小鼠出现心肌肥大,但AC(VI)的心脏表达可消除这种肥大,这通过心室重量与胫骨长度之比得到证实(Gq组,11.93±0.99 mg/mm,n = 11;Gq/AC组,8.00±0.73 mg/mm,n = 9;P<0.01),以及左心室心肌细胞大小(Gq组,2800±254 μm2,n = 4;Gq/AC组,1721±166 μm2,n = 5;P<0.01)。Gq小鼠的心脏扩张,功能受损。AC的共表达可减小舒张末期直径(Gq组,4.20±0.15 mm,n = 12;Gq/AC组,3.68±0.12 mm,n = 7;P<0.05)并增加缩短分数(Gq组,32±1%,n = 12;Gq/AC组,41±2%,n = 7;P<0.001)。Gq/AC小鼠的心肌细胞显示福斯可林刺激的cAMP生成增加(Gq组,3.8±1.3 fmol/细胞,n = 5;Gq/AC组,10.7±2.6 fmol/细胞,n = 6;P<0.02),证明AC功能增强。

结论

心脏定向表达AC(VI)可恢复心肌细胞AC功能,改善心脏功能,增加cAMP生成,消除心肌肥大,并提高Gq心肌病小鼠的生存率。

相似文献

1
Adenylyl cyclase increases survival in cardiomyopathy.腺苷酸环化酶可提高心肌病患者的生存率。
Circulation. 2002 Apr 23;105(16):1989-94. doi: 10.1161/01.cir.0000014968.54967.d3.
2
Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy.心脏定向腺苷酸环化酶表达可改善小鼠心肌病的心脏功能。
Circulation. 1999 Jun 22;99(24):3099-102. doi: 10.1161/01.cir.99.24.3099.
3
Controlled expression of cardiac-directed adenylylcyclase type VI provides increased contractile function.心脏定向性腺苷酸环化酶VI的可控表达可增强收缩功能。
Cardiovasc Res. 2002 Nov;56(2):197-204. doi: 10.1016/s0008-6363(02)00539-4.
4
Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction.心肌梗死发生后,心脏腺苷酸环化酶表达增加与生存率提高相关。
Circulation. 2006 Aug 1;114(5):388-96. doi: 10.1161/CIRCULATIONAHA.106.632513. Epub 2006 Jul 24.
5
Disruption of adenylyl cyclase type V does not rescue the phenotype of cardiac-specific overexpression of Galphaq protein-induced cardiomyopathy.腺苷酸环化酶 V 型的破坏不能挽救心脏特异性过表达 Galphaq 蛋白诱导的心肌病表型。
Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1459-67. doi: 10.1152/ajpheart.01208.2009. Epub 2010 Aug 13.
6
Cardiac-directed expression of adenylyl cyclase reverses electrical remodeling in cardiomyopathy.腺苷酸环化酶的心脏定向表达可逆转心肌病中的电重构。
J Mol Cell Cardiol. 2006 Jul;41(1):170-81. doi: 10.1016/j.yjmcc.2006.04.008. Epub 2006 Jun 5.
7
Adenylyl cyclase type VI gene transfer reduces phospholamban expression in cardiac myocytes via activating transcription factor 3.VI型腺苷酸环化酶基因转移通过激活转录因子3降低心肌细胞中受磷蛋白的表达。
J Biol Chem. 2004 Sep 10;279(37):38797-802. doi: 10.1074/jbc.M405701200. Epub 2004 Jul 1.
8
Adenylyl cyclase: a new target for heart failure therapeutics.
Circulation. 2002 Apr 23;105(16):1876-8. doi: 10.1161/01.cir.0000016965.24080.12.
9
Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice.激活心脏腺苷酸环化酶表达可增强小鼠缺血性衰竭心脏的功能。
J Am Coll Cardiol. 2008 Apr 15;51(15):1490-7. doi: 10.1016/j.jacc.2008.01.015.
10
Transgenic replacement of type V adenylyl cyclase identifies a critical mechanism of beta-adrenergic receptor dysfunction in the G alpha q overexpressing mouse.V型腺苷酸环化酶的转基因替代揭示了Gαq过表达小鼠中β-肾上腺素能受体功能障碍的关键机制。
FEBS Lett. 1999 Sep 17;458(2):236-40. doi: 10.1016/s0014-5793(99)01147-3.

引用本文的文献

1
Regulation of β-Adrenergic Receptors in the Heart: A Review on Emerging Therapeutic Strategies for Heart Failure.β-肾上腺素受体在心脏中的调控:心力衰竭治疗新策略的综述。
Cells. 2024 Oct 10;13(20):1674. doi: 10.3390/cells13201674.
2
Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions.心脏病理生理学中的纳米域环磷酸腺苷信号传导:开发靶向治疗干预措施的潜力
Physiol Rev. 2025 Apr 1;105(2):541-591. doi: 10.1152/physrev.00013.2024. Epub 2024 Aug 8.
3
Adenylyl cyclase isoforms 5 and 6 in the cardiovascular system: complex regulation and divergent roles.
心血管系统中的腺苷酸环化酶同工型5和6:复杂的调节与不同的作用
Front Pharmacol. 2024 Apr 3;15:1370506. doi: 10.3389/fphar.2024.1370506. eCollection 2024.
4
Metabolic Acidosis Results in Sexually Dimorphic Response in the Heart Tissue.代谢性酸中毒导致心脏组织出现性别差异反应。
Metabolites. 2023 Apr 12;13(4):549. doi: 10.3390/metabo13040549.
5
Deciphering the Basis of Molecular Biology of Selected Cardiovascular Diseases: A View on Network Medicine.解析选定心血管疾病的分子生物学基础:网络医学视角。
Int J Mol Sci. 2022 Sep 28;23(19):11421. doi: 10.3390/ijms231911421.
6
Signaling cascades in the failing heart and emerging therapeutic strategies.衰竭心脏中的信号级联反应和新兴治疗策略。
Signal Transduct Target Ther. 2022 Apr 23;7(1):134. doi: 10.1038/s41392-022-00972-6.
7
Physiological roles of mammalian transmembrane adenylyl cyclase isoforms.哺乳动物跨膜腺苷酸环化酶同工型的生理作用。
Physiol Rev. 2022 Apr 1;102(2):815-857. doi: 10.1152/physrev.00013.2021. Epub 2021 Oct 26.
8
Compartmentalized Signaling in Aging and Neurodegeneration.衰老和神经退行性疾病中的分隔信号转导。
Cells. 2021 Feb 22;10(2):464. doi: 10.3390/cells10020464.
9
Cardiac T-Tubule cBIN1-Microdomain, a Diagnostic Marker and Therapeutic Target of Heart Failure.心脏 T 管 cBIN1-微区:心力衰竭的诊断标志物和治疗靶点。
Int J Mol Sci. 2021 Feb 25;22(5):2299. doi: 10.3390/ijms22052299.
10
Cardiac adenylyl cyclase overexpression precipitates and aggravates age-related myocardial dysfunction.心脏腺苷酸环化酶过表达加剧与年龄相关的心肌功能障碍。
Cardiovasc Res. 2019 Oct 1;115(12):1778-1790. doi: 10.1093/cvr/cvy306.